1 November 2018

Wikipedia The Radboud Center for Oncology is initiating the Radboud Biobank Oncology in the Radboudumc. This oncology biobank will be part of the Radboud Biobank.

The Radboud Center for Oncology is initiating the Radboud Biobank Oncology in the Radboudumc. This oncology biobank will be part of the Radboud Biobank. Biomaterial and associated clinical data will be collected of each patient with cancer who visits the Radboudumc for diagnosis or treatment. The Radboud Biobank Oncology aims to make a significant impact on cancer care. Peggy Manders (manager of the Radboud Biobank) is responsible for the implementation of this biobank initiative.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items


One year since the new business model for the Radboud Biobank was implemented

3 March 2026

The new business model was introduced last year, with departments paying half of the biomaterial processing costs, covering the storage costs, and applying a graduated rate for sample issuance.

go to page

Periodic invoicing biobank collections

3 March 2026

Since 2025, the Radboud Biobank periodically charges all biobank collections for the processing and storage costs incurred.

go to page

The purpose of a central biobank facility such as the Radboud Biobank

3 March 2026

As the central biobank facility of Radboudumc, the Radboud Biobank does more than simply store human biomaterials.

go to page

Radboud Biobank's 2025 annual report

3 March 2026

The Radboud Biobank's 2025 annual report is now available on request.

go to page

Aevai Health developed a virtual assistant

3 March 2026

Aevai Health has developed Alva - a virtual assistant to engage research participants, which can support participants with health literacy, understanding research protocols, and with using measurement devices.

go to page

Radboudumc Researchers Highlight Critical Gaps in Reporting Pre-Analytical Processes in Biobanked Biomaterials

21 October 2025

Radboudumc Researchers have identified significant shortcomings in pre-analytical sample processing reporting in clinical biomarker research, a factor crucial for study reliability and replicability.

go to page